Previous studies have suggested that c-Src phosphorylates ETS1, resulting in increased stabilization of ETS1 as it is not degraded by the E3 ligase COP1, leading to increased tumor progression (Lu et al., 2014). The gene discussed is SRC; the disease is neoplasm.